• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.36% Nasdaq Up 0.39%

    Tekmira Pharmaceuticals Corporation (TKMR)

    -NasdaqCM
    13.95 Up 0.40(2.95%) 1:47PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:13.55
    Open:13.60
    Bid:13.97 x 100
    Ask:13.99 x 200
    1y Target Est:28.00
    Beta:-0.76
    Earnings Date:Aug 11 - Aug 17 (Est.)
    Day's Range:13.41 - 14.02
    52wk Range:8.86 - 29.93
    Volume:575,004
    Avg Vol (3m):797,456
    Market Cap:756.42M
    P/E (ttm):N/A
    EPS (ttm):-1.36
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    TKMRUp 2.95%756.42M
    MRNADown 5.13%N/A
    RXIIUp 3.53%13.99M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):48.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.41
    Quarterly EPS Est (Jun-15) :-0.26
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Tekmira Pharmaceuticals Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics; and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback